MDI Biological Laboratory

Topic: Biotechnology

Pioneering New Kidney-Grafting Techniques

New research published in the journal Bioengineering was led by former visiting scientists Leif Oxburgh, D.V.M., Ph.D. and Denise Marciano, M.D., Ph.D., and the MDI Bio Lab’s Iain Drummond, Ph.D.  Drummond calls the challenge of getting lab-grown kidney tissue to link with an organism's circulatory system and function properly a "plumbing problem." 

Continue Reading

Data Science Team Explores New Protein Functions

Data Science Core Director Joel Graber, Ph.D., and several of his MDI Bio Lab Core team are co-authors of a new publication in Genetics that details previously undescribed molecular and genetic functions of a protein in yeast that is conserved in humans.

Continue Reading

A Post-Doc Builds Proto-Kidneys from Scratch

More than 30 million Americans suffer from chronic kidney disease (CKD), including thousands in Maine. 

Continue Reading

Microscopy in Focus for Maine INBRE Students

Students and young science faculty from all around Maine converged on MDI Bio Lab’s campus for an intensive 10-day course on the use of the most modern microscopy of the day.

Continue Reading

MDI Bio Lab and the Roux Institute Join Forces to Boost Maine’s Biotech Workforce

Sharing faculty and resources to train a new generation of scientists 

Continue Reading

Senator Collins Supports $1.6 million for MDI Bioscience in Appropriations Bill

If enacted by Congress, the measure will support new campus infrastructure for drug discovery 

Continue Reading

Biomedical Science and MDI Bio Lab in the Spotlight

Wide-ranging discussions of biomedical research and its role in Maine’s scientific community and economy happening across the state.

Continue Reading

A New Generation of Biotech Entrepreneurs

Collaboration by MDI Bio Lab and Colby College supports young innovators

Continue Reading

A Busy First Year at MDI Bioscience, Capped by Support from Capitol Hill

It’s been almost a year since MDIBL announced the formation of MDI Bioscience, a new Laboratory initiative focused on using non-mammalian models for human health, such as zebrafish and C. elegans roundworms, in early-stage drug discovery and development.

Continue Reading
1 2 3